A 38-year-old woman with a history of shellfish allergy presents for contrast-enhanced MRI of the brain. Which is the most common type of adverse reaction to gadolinium-based contrast agents (GBCAs) in patients with documented IgE-mediated allergies?

Explanation

## Adverse Reactions to Gadolinium-Based Contrast Agents **Key Point:** The most common adverse reaction to GBCAs in patients with IgE-mediated allergies is immediate hypersensitivity, manifesting as urticaria, angioedema, bronchospasm, or anaphylaxis within minutes of injection. ### Classification of GBCA Reactions | Reaction Type | Timing | Mechanism | Frequency | Clinical Features | |---|---|---|---|---| | **Immediate hypersensitivity** | Minutes | IgE-mediated mast cell/basophil degranulation | 0.1–0.2% (higher in atopic patients) | Urticaria, pruritus, angioedema, bronchospasm, hypotension, anaphylaxis | | **Delayed hypersensitivity** | 24–48 hrs | T-cell mediated (Type IV) | 0.5–2.7% | Exanthema, fever, lymphadenopathy | | **Nephrogenic systemic fibrosis (NSF)** | Days–months | Gadolinium deposition in tissue (linear agents) | Rare; <0.1% (now obsolete) | Skin induration, fibrosis, systemic involvement | | **Osmotic diuresis** | During/after infusion | Osmotic load | Rare in MRI (low osmolarity) | Transient renal hypoperfusion | ### Risk Stratification for GBCA Reactions **High-Yield:** Cross-reactivity between iodinated contrast media (used in CT) and GBCAs (used in MRI) is **extremely low** (~1–2%), despite both being contrast agents. Shellfish allergy does NOT contraindicate GBCA use. **Clinical Pearl:** The incidence of immediate hypersensitivity to GBCAs is **lower** than to iodinated contrast media (0.1–0.2% vs. 0.1–1% for ionic iodinated agents), because GBCAs are non-ionic, chelated molecules with minimal osmolarity. ### Management of Patients with Prior Contrast Allergy 1. **Pre-medication regimen** (if GBCA is essential): - Methylprednisolone 32 mg PO 12 and 2 hours before injection - Diphenhydramine 50 mg IV/IM 1 hour before injection - Omeprazole 20 mg PO 2 hours before injection (optional) 2. **Use non-ionic, macrocyclic GBCAs** (gadoteridol, gadometerol) — lower risk than linear agents. 3. **Have emergency equipment and medications on hand** (epinephrine, IV access, oxygen). **Mnemonic: GBCA SAFETY** — Gadolinium chelation (reduces free Gd³⁺), Baseline renal function (eGFR > 30 for safe use), Chelated molecules (non-ionic), Allergy history (assess cross-reactivity), Safe in most atopic patients, Fewer osmotic effects than iodinated agents, Emergencies rare but prepare, Time-dependent NSF risk (now obsolete with macrocyclic agents), Yield of imaging justifies risk. [cite:Harrison 21e Ch 279; ACR Manual on Contrast Media 10e]